Direct In Vivo evidence for tumor propagation by glioblastoma cancer stem cells

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Lathia, Justin D ^a   Gallagher, Joseph ^a   Myers, Jay T ^b   Li, Meizhang ^a   Vasanji, Amit ^a,d   McLendon, Roger E ^c   Hjelmeland, Anita B ^a,b   Huang, Alex Y ^b   Rich, Jeremy N ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

^d ImageIQ   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER STEM CELL; CELL CYCLE M PHASE; CELL HETEROGENEITY; CELL POPULATION; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGING; IMMUNOPHENOTYPING; IN VIVO STUDY; MOUSE; NONHUMAN; PHENOTYPE; TUMOR VASCULARIZATION; TUMOR XENOGRAFT; XENOTRANSPLANTATION; ADULT; ANIMAL; BLOOD VESSEL; BRAIN TUMOR; CANCER TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MULTIPHOTON MICROSCOPY; NUDE MOUSE; PATHOLOGY; TUMOR CELL CULTURE; TUMOR MICROENVIRONMENT; TUMOR VOLUME; VASCULARIZATION; XENOGRAFT;

CD133 ANTIGEN; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE; PHOTOPROTEIN;

ADULT; ANIMALS; ANTIGENS, CD; BLOOD VESSELS; BRAIN NEOPLASMS; CELL PROLIFERATION; GLIOBLASTOMA; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; LUMINESCENT PROTEINS; MALE; MICE; MICE, NUDE; MICROSCOPY, FLUORESCENCE, MULTIPHOTON; NEOPLASM TRANSPLANTATION; NEOPLASTIC STEM CELLS; PEPTIDES; TRANSPLANTATION, HETEROLOGOUS; TUMOR BURDEN; TUMOR CELLS, CULTURED; TUMOR MICROENVIRONMENT;

EID: 80053058993     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024807     Document Type: Article

References (33)

1. Anderson K, Lutz C, van Delft FW, Bateman CM, Guo Y, et al. (2011) Genetic variegation of clonal architecture and propagating cells in leukaemia. Nature 469: 356-361.
2. Reya T, Morrison SJ, Clarke MF, Weissman IL, (2001) Stem cells, cancer, and cancer stem cells. Nature 414: 105-111.
3. Quintana E, Shackleton M, Sabel MS, Fullen DR, Johnson TM, et al. (2008) Efficient tumour formation by single human melanoma cells. Nature 456: 593-598.
4. Rosen JM, Jordan CT, (2009) The increasing complexity of the cancer stem cell paradigm. Science 324: 1670-1673.
5. Colmone A, Amorim M, Pontier AL, Wang S, Jablonski E, et al. (2008) Leukemic cells create bone marrow niches that disrupt the behavior of normal hematopoietic progenitor cells. Science 322: 1861-1865.
6. Lo Celso C, Fleming HE, Wu JW, Zhao CX, Miake-Lye S, et al. (2009) Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche. Nature 457: 92-96.
7. Mendez-Ferrer S, Michurina TV, Ferraro F, Mazloom AR, Macarthur BD, et al. (2010) Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466: 829-834.
8. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, et al. (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444: 756-760.
9. Mostany R, Portera-Cailliau C, (2008) A craniotomy surgery procedure for chronic brain imaging. J Vis Exp Feb 15 (12).
10. Kienast Y, von Baumgarten L, Fuhrmann M, Klinkert WE, Goldbrunner R, et al. (2010) Real-time imaging reveals the single steps of brain metastasis formation. Nat Med 16: 116-122.
11. Lathia JD, Gallagher J, Heddleston JM, Wang J, Eyler CE, et al. (2010) Integrin alpha 6 regulates glioblastoma stem cells. Cell Stem Cell 6: 421-432.
12. Bao S, Wu Q, Li Z, Sathornsumetee S, Wang H, et al. (2008) Targeting cancer stem cells through L1CAM suppresses glioma growth. Cancer Res 68: 6043-6048.
13. Ogden AT, Waziri AE, Lochhead RA, Fusco D, Lopez K, et al. (2008) Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas. Neurosurgery 62: 505-514; discussion 514-505.
14. Guryanova OA, Wu Q, Cheng L, Lathia JD, Huang Z, et al. (2011) Nonreceptor Tyrosine Kinase BMX Maintains Self-Renewal and Tumorigenic Potential of Glioblastoma Stem Cells by Activating STAT3. Cancer Cell 19: 498-511.
15. Eyler CE, Wu Q, Yan K, Macswords JM, Chandler-Militello D, et al. (2011) Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2. Cell 146: 53-66.
16. Calabrese C, Poppleton H, Kocak M, Hogg TL, Fuller C, et al. (2007) A perivascular niche for brain tumor stem cells. Cancer Cell 11: 69-82.
17. Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, et al. (2004) Identification of human brain tumour initiating cells. Nature 432: 396-401.
18. Li Z, Bao S, Wu Q, Wang H, Eyler C, et al. (2009) Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell 15: 501-513.
19. Gangemi RM, Griffero F, Marubbi D, Perera M, Capra MC, et al. (2009) SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity. Stem Cells 27: 40-48.
20. Pallini R, Ricci-Vitiani L, Banna GL, Signore M, Lombardi D, et al. (2008) Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme. Clin Cancer Res 14: 8205-8212.
21. El Hallani S, Boisselier B, Peglion F, Rousseau A, Colin C, et al. (2010) A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry. Brain 133: 973-982.
22. Wang R, Chadalavada K, Wilshire J, Kowalik U, Hovinga KE, et al. (2010) Glioblastoma stem-like cells give rise to tumour endothelium. Nature.
23. Ricci-Vitiani L, Pallini R, Biffoni M, Todaro M, Invernici G, et al. (2010) Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells. Nature.
24. Soda Y, Marumoto T, Friedmann-Morvinski D, Soda M, Liu F, et al. (2011) Transdifferentiation of glioblastoma cells into vascular endothelial cells. Proc Natl Acad Sci U S A 108: 4274-4280.
25. Sun A, Hou L, Prugpichailers T, Dunkel J, Kalani MA, et al. (2010) Firefly luciferase-based dynamic bioluminescence imaging: a noninvasive technique to assess tumor angiogenesis. Neurosurgery 66: 751-757; discussion 757.
26. Dinca EB, Sarkaria JN, Schroeder MA, Carlson BL, Voicu R, et al. (2007) Bioluminescence monitoring of intracranial glioblastoma xenograft: response to primary and salvage temozolomide therapy. J Neurosurg 107: 610-616.
27. Zhou BB, Zhang H, Damelin M, Geles KG, Grindley JC, et al. (2009) Tumour-initiating cells: challenges and opportunities for anticancer drug discovery. Nat Rev Drug Discov 8: 806-823.
28. Bao S, Wu Q, Sathornsumetee S, Hao Y, Li Z, et al. (2006) Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Res 66: 7843-7848.
29. Norden AD, Young GS, Setayesh K, Muzikansky A, Klufas R, et al. (2008) Bevacizumab for recurrent malignant gliomas: efficacy, toxicity, and patterns of recurrence. Neurology 70: 779-787.
30. Bergers G, Hanahan D, (2008) Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer 8: 592-603.
31. Jain RK, Tomaso Ed, Duda DG, Loeffler JS, Sorensen AG, et al. (2007) Angiogenesis in brain tumors. Nature 8: 610-622.
32. Low JA, de Sauvage FJ, (2010) Clinical experience with Hedgehog pathway inhibitors. J Clin Oncol 28: 5321-5326.
33. Olive KP, Jacobetz MA, Davidson CJ, Gopinathan A, McIntyre D, et al. (2009) Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 324: 1457-1461.